Provide Proven Precise and Effective Clinical SolutionsMORE >
My Bio-Med Biotechnology Co., Ltd (MBM) was founded in 2016 in Ningbo, Zhejiang Province, China.
Today, MBM business covers precision medicine; AI & digital pathology, tumor early detection, dignosis and prognosis biomarkers, as well as in other diseases areas.
MBM is committed to "Bridging World Innovations in Precision Medicine". We are the first platfrom in China in precision medicine for transformation and commercialization of diagnostics, treatment and medical AI technologies.
MBM introduces leading technologies and products which are clinically proven, with lean focus on oncology and cardiovascular.
MBM well supports technology transformation and re-development, which follows a clear market entry strategy, on our diversified technology platform. Supported by a solid marketing and sales team of senior experts of the industry, MBM successfully launchs and promotes new products in China and rest of the worlds.
MBM owns a clincial laboratory that fully fits CLIA and CAP standards.
MBM Clinical Lab Passed External Quality Assessment （EQA） by MoH with Full Mark
MBM Completes series A fundraising by Puhua Capital
ColoProg UK-China Joint Launch